Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 641 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Workout Wednesday – Upper Body Stretches July 1, 2020 Rucaparib Approved as Maintenance Treatment for Some Recurrent Ovarian Cancers May 4, 2018 How to Cope with Appetite Loss in a Loved One With... July 6, 2021 FDA Approves Zolbetuximab-clzb with Chemotherapy for Gastric or Gastro-Oesophageal Junction Adenocarcinoma November 13, 2024 Load more HOT NEWS How Joining a Clinical Trial Helped Me Find Hope While Living... How Does Ovarian Cancer Form? A New Study Points to MicroRNA FDA Grants Accelerated Approval to Sotorasib for KRAS G12C-mutated NSCLC ASCO 2021 news: follow-up treatments pave the way
